Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
about
Apoptosis inducing effect of plumbagin on colonic cancer cells depends on expression of COX-2The RAF inhibitor PLX4032 inhibits ERK signaling and tumor cell proliferation in a V600E BRAF-selective mannerCooperation of ERK and SCFSkp2 for MKP-1 destruction provides a positive feedback regulation of proliferating signalingDisruption of CRAF-mediated MEK activation is required for effective MEK inhibition in KRAS mutant tumorsKinase-dead BRAF and oncogenic RAS cooperate to drive tumor progression through CRAFThe phosphorylation of CapZ-interacting protein (CapZIP) by stress-activated protein kinases triggers its dissociation from CapZThe tRNA methylase METTL1 is phosphorylated and inactivated by PKB and RSK in vitro and in cells.A novel UBA and UBX domain protein that binds polyubiquitin and VCP and is a substrate for SAPKsRelief of profound feedback inhibition of mitogenic signaling by RAF inhibitors attenuates their activity in BRAFV600E melanomasExploitation of KESTREL to identify NDRG family members as physiological substrates for SGK1 and GSK3Identification of filamin C as a new physiological substrate of PKBalpha using KESTRELWNK1, the kinase mutated in an inherited high-blood-pressure syndrome, is a novel PKB (protein kinase B)/Akt substrateAntagonistic effects of phorbol esters on insulin regulation of insulin-like growth factor-binding protein-1 (IGFBP-1) but not glucose-6-phosphatase gene expressionRegulation of elongation factor 2 kinase by p90(RSK1) and p70 S6 kinase.Inhibition of SAPK2a/p38 prevents hnRNP A0 phosphorylation by MAPKAP-K2 and its interaction with cytokine mRNAsThe selectivity of protein kinase inhibitors: a further updateGrb2-SH3 ligand inhibits the growth of HER2+ cancer cells and has antitumor effects in human cancer xenografts alone and in combination with docetaxelPhosphorylation of the ARE-binding protein DAZAP1 by ERK2 induces its dissociation from DAZUse of mitogenic cascade blockers for treatment of C-Raf induced lung adenoma in vivo: CI-1040 strongly reduces growth and improves lung structureModulating sensitivity to drug-induced apoptosis: the future for chemotherapy?Finding the needle in the haystack: why high-throughput screening is good for your health.Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosisActivation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation.Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expressionMechanistic and Structural Understanding of Uncompetitive Inhibitors of Caspase-6Phase I pharmacokinetic and pharmacodynamic study of the oral, small-molecule mitogen-activated protein kinase kinase 1/2 inhibitor AZD6244 (ARRY-142886) in patients with advanced cancersPhosphorylation of the protein kinase mutated in Peutz-Jeghers cancer syndrome, LKB1/STK11, at Ser431 by p90(RSK) and cAMP-dependent protein kinase, but not its farnesylation at Cys(433), is essential for LKB1 to suppress cell vrowthBiophytum sensitivum (L.) DC inhibits tumor cell invasion and metastasis through a mechanism involving regulation of MMPs, prolyl hydroxylase, lysyl oxidase, nm23, ERK-1, ERK-2, STAT-1, and proinflammatory cytokine gene expression in metastatic lungThe ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transitionSpecificity and mechanism of action of some commonly used protein kinase inhibitorsTherapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemiaEGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cellsEffect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trialCross-talk between signalling pathways and the multidrug resistant protein MDR-1A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibitionInhibition of transforming growth factor-activated kinase 1 (TAK1) blocks and reverses epithelial to mesenchymal transition of mesothelial cellsBAY61-3606 affects the viability of colon cancer cells in a genotype-directed mannerThe protein kinase TPL2 is essential for ERK1/ERK2 activation and cytokine gene expression in airway epithelial cells exposed to pathogen-associated molecular patterns (PAMPs)BRAF mutation predicts sensitivity to MEK inhibitionProtein kinases--the major drug targets of the twenty-first century?
P2860
Q21560840-8EEA3058-653D-438D-AF55-4ED485AB4C37Q21629049-08148053-623C-40E7-9E51-AB18A3D4388FQ24294827-FA863443-A611-4C40-879F-0CD0CD2E8A89Q24294914-99F3E3F2-E8A7-438E-B233-08ED7CCC9882Q24298749-1235A18A-1CE2-428B-B35A-4093F5E49578Q24300649-DE664660-CC0B-483C-AF59-C57601C8B9E7Q24301036-B83FD402-0800-465E-B953-F8B4E5D46AAFQ24303684-F1405D2F-6CFC-470D-BF93-0796899E0D2EQ24303940-B69E46DF-A518-469B-B2F8-20A37012BC70Q24528133-54F46E49-56D1-4D9E-AB34-8F67F64535ADQ24528134-49D46ADC-25D3-42B9-A836-C974E63690D0Q24530650-69ACC187-E980-42D2-903C-7385CE948F67Q24533515-E2A620EC-AB47-4E94-9011-A9CC71F196C7Q24535599-CDDDE09C-E84D-44F6-9FF6-E6E46AF56B35Q24539187-66301ECD-B093-4DDB-B8FE-D7FD10ED8313Q24654622-E77AD3C5-E84E-40DB-9792-80039C51A03AQ24658331-59AFDDF2-38C9-470C-B1CC-1E57F02FA761Q24673616-5AFBD956-D073-4618-873B-4F42F02FF469Q24797025-6D86C2F8-9C7E-4647-BA8B-BF0115DC382AQ24801341-47FC97AC-98CA-433F-B9D2-9C9BADA272DAQ24802613-9DE2EA10-1D6D-4137-AF70-AB5BC9F9BDC1Q24805089-A6F16EBB-4C1A-483A-9726-218ED2D7D9F0Q24816886-397EFDFF-87BC-438E-8A3E-743354C1C574Q25257709-08B43B66-8E8C-4670-9D1A-5F652137FA8AQ27675436-9C6DE5D6-1A91-483D-BE64-60F76A37B064Q27851426-D42C0ED2-ABF2-4CFB-A0F2-00694F7ACFDEQ28211693-EBC190D2-1C58-4435-B28D-B0A0812D0A1DQ28269683-9367A081-A5BD-4D6B-83D7-382320B3821DQ28301955-B3435445-65DF-4718-B47B-F4709883BFC5Q28344791-31663E91-1F1A-421F-A8C8-22EBD2CC6519Q28354257-0808041F-4340-43AF-9583-88E0D186C627Q28360903-A1C45283-BC22-4294-B5BC-821138BE7098Q28361953-E4B8EABE-2902-43ED-AFE9-337E4B6DE976Q28364226-441C09CF-C773-4392-AB75-A2D0D64B3181Q28477181-1E9DBEB0-5B7E-4671-9C6A-0142AFCCFA5AQ28481277-7D8FB4C4-26BA-4180-9011-E9E86FA57522Q28481390-55A45DD9-1B4C-420F-999D-5DA3BE128737Q28488321-6BA12CDC-E15A-4882-9C7A-1D8495225578Q29614281-2ED585DC-47EF-4F4D-8F1F-CFA066C81BC7Q29615339-604C7A2B-6A4A-4EA1-BB25-C1E6EC015659
P2860
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@ast
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@en
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@nl
type
label
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@ast
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@en
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@nl
prefLabel
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@ast
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@en
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@nl
P2093
P3181
P356
P1433
P1476
Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo
@en
P2093
Barrett SD
Leopold WR
Przybranowski S
Sebolt-Leopold JS
Van Becelaere K
P2888
P304
P3181
P356
10.1038/10533
P407
P577
1999-07-01T00:00:00Z